A parallel arm interventional clinical Study to assess the efficacy and tolerability of ointment with natural ingredient in patients with chronic osteoarthritis of knee and low back ache
DOI:
https://doi.org/10.56511/JIPBS.2022.9302Abstract
Background: Treatment of OA focuses on reducing symptoms. Such treatment can be analgesic or nonsteroidal anti-inflammatory agents. With the current frequency and severity of adverse effects from analgesics and NSAIDs, suggestions for safer and sustainable interventions to manage the pain and stiffness are warranted. Natural local remedies, because of their relative safety, may reduce dependency on NSAIDs and analgesics and could have an important role in the treatment of OA. Trial design: Trial was parallel arm involving 60 patients with chronic osteoarthritis of knee and low back ache included in two parallel groups, Treatment Group (AVI- TR 01), and Control Group (n = 30/group). Methodology: The study involved assessment of changes in pain score with VAS, changes in WOMAC score, changes in severity of other symptoms like swelling, tenderness between treatment and control groups for the period of 14 days. Results and conclusion: It can be concluded that AVI- TR 01 treatment for pain and stiffness in patients with osteoarthritis by proving relief from pain, swelling, stiffness etc. It led to improvement in quality of life for the patients. There was reduction in the requirement of oral analgesics for the subjects using regular AVI- TR 01 for 14 days. Thus it can be concluded from the present study that the treatment with AVI- TR 01 is safe and effective solution to manage pain and stiffness in osteoarthritis
Keywords:
Osteoarthritis, Pain balm, VAS, HerbalDownloads
References
Prieto - Alhambra D, Judge A, Javaid MK, Cooper C, Diez - Perez A, Arden NK. Incidence and risk factors for clinically diagnosed knee, hip and hand osteoarthritis: influences of age, gender and osteoarthritis affecting other joints. Annals of th e rheumatic diseases. 2014 ; 73(9):1659 - 64.
Hunter DJ, Schofield D, Callander E. The individual and socioeconomic impact of osteoarthritis. Natur e Reviews Rheumatology. 2014 ; 10(7):437.
Runciman WB, Hunt TD, Hannaford NA, Hibbert PD, Westbrook JI, Coiera EW, Day RO, Hindmarsh DM, McGlynn EA, Braithwaite J. CareTrack: assessing the appropriateness of health care delivery in Australia. Medica l Journal of Australia. 2012 ; 197(2):100 - 5.
Pal CP, Singh P, Chaturvedi S, Pruthi KK, Vij A. Epidemiology of knee osteoarthritis in India and related factors. Indian j ournal of orthopaedics. 2016 ; 50:518 - 22
Tramèr MR, Moore RA, Reynolds DJ, McQuay HJ. Quantitative estimation of rare adverse events which follow a biological progression: a new mode l applied to chr onic NSAID use. Pain. 2000 ; 85(1 - 2):169 - 82.
Weinberger M, Tierney WM, Booher P, Katz BP. Can the provision of information to patients with osteoarthritis improve functional status?. A randomized, controlled trial. Arthritis & Rheumatism: Of ficial Journal of the American C ollege of Rheumatology. 1989 ; 32(12):1577 - 83.
Long L, Soeken K, Ernst E. Herbal medicines for the treatment of osteoarthritis: a systemati c review. Rheumatology. 2001 ; 40(7):779 - 93 .
Nerys F. Woolacott, Mark S. Corbett, Steph en J. C. Rice, The use and reporting of WOMAC in the assessment of the benefit of physical therapies for the pain of osteoarthritis of the knee: findings from a systematic review of clinical trials, Rheumatology , Volume 51, Issue 8, August 2012, Pages 1440 – 1446, https://doi.org/10.1093/rheumatology/kes043
Ware JE Jr, Keller SD, Hatoum HT, Kong SX. The SF - 36 Arthritis - Specific Health Index (ASHI): I. Development and cross - validation of scorin g algorithms. Med Care. 1999 ; 37(5 Suppl):MS40 - 50. doi: 10.1097/00005650 - 199905001 - 00004. PMID: 10335742.
Published
How to Cite
Issue
Section
Copyright (c) 2022 Dr Umesh Gajare, Dr Gayatri Ganu, Dr Dheeraj Nagore, Ashish Nagoakar

This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.


Journal of Innovations in Pharmaceutical and Biological Sciences is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License. Based on a work at